The updated filing for the tech-focused SPAC follows a previous filing to downsize its IPO to $220 million from $275 million. Read more.
Roman DBDR Updates Prospectus
Related Posts
Screaming Eagle Amends Prospectus on $4.6B Lionsgate Studio Deal with Additional PIPE Funds
There is a minimum $350 million cash condition to seal the deal. A PIPE of $175 million is already committed.
Evo Acquisition Hits Up Sponsor for $1.5M
Evo raised $100 million in a February 2021 IPO, saying at the time it would concentrate on companies in the technology and financial sectors.
First Digital Health Acquisition Files for $175M IPO
The new SPAC will target companies in the healthcare technology, healthcare technology-enabled services, or digital health subsectors.
Greenrose Plans PIPE to Cover Cannabis Acquisitions
The SPAC in March announced definitive agreements to acquire four cannabis companies: Shango Holdings, Futureworks, (d/b/a The Health Center), Theraplant and True Harvest.